In many of the listed noncardiac conditions, the BNP or NT-proBNP elevation is mediated by a cardiac condition. BNP: B-type natriuretic peptide; NT-proBNP: N-terminal pro-BNP. * Some snake venom contains natriuretic peptide.

Natriuretic peptide levels are elevated in some patients with coronary heart disease, valvular heart disease, constrictive pericarditis, pulmonary hypertension, and sepsis . The diagnostic and prognostic value of measuring plasma BNP and NT-proBNP in asymptomatic individuals and patients with such non-HF conditions is discussed here.

The release of both ANP and BNP is increased in heart failure (HF), as ventricular myocytes are stimulated to secrete both ANP and BNP in response to increased strain caused by high ventricular filling pressures and increased exposure to …

2024年4月17日 · Potential causes of troponin elevation unrelated to coronary thrombosis will be reviewed here. Other related topics include: (See "Troponin testing: Clinical use" .)

2024年12月4日 · For some patients with symptoms and conflicting clinical data (eg, increasing dyspnea, decreasing weight), we obtain a B-type natriuretic peptide (BNP) or N-terminal pro-BNP level, but we do not obtain BNP levels as part of routine monitoring. (See "Natriuretic peptide measurement in heart failure".)

2023年10月17日 · Possible causes; Impact of preexisting cardiovascular disease; ACUTE CLINICAL MANIFESTATIONS. Asymptomatic heart disease; Myocardial injury - Myocarditis - Stress cardiomyopathy - Myocardial infarction; Heart failure - General prevalence - Right heart failure - Cardiogenic shock - Multisystem inflammatory syndrome in adults (MIS-A) Cardiac ...

Lactate levels greater than 2 mmol/L represent hyperlactatemia, whereas lactic acidosis is generally defined as a serum lactate concentration above 4 mmol/L. Lactic acidosis is the most common cause of metabolic acidosis in hospitalized patients.

Natriuretic peptides (BNP and NT-proBNP) are commonly elevated in hospitalized patients with COVID-19, and natriuretic peptide elevation is associated with mortality … Heart failure with preserved ejection fraction: Clinical manifestations and diagnosis

Cardiac dysfunction, pericarditis, valvulitis, or coronary abnormalities (including echocardiographic findings or elevated troponin/BNP) Evidence of coagulopathy (prolonged PT or PTT; elevated D-dimer)

2019年12月5日 · Use — For patients with clear evidence of HFpEF and current or recent (eg, within 60 days) elevated natriuretic peptide (either brain natriuretic peptide [BNP] ≥100 pg per mL or N-terminal pro-BNP [NT-proBNP] ≥360 pg per mL) who can be carefully monitored for changes in serum potassium and renal function, we suggest treatment with a ...